$1.36
+0.00 (+0.00%)
Open$1.38
Previous Close$1.36
Day High$1.40
Day Low$1.35
52W High$9.37
52W Low$1.16
Volume—
Avg Volume18.3K
Market Cap4.74M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+233.8% upside
Current
$1.36
$1.36
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.11M | 7.07M | 1.27M |
| Net Income | -9,930,353 | -7,790,548 | 357.5K |
| Profit Margin | -122.5% | -116.3% | 28.2% |
| EBITDA | -10,235,780 | -8,476,282 | 531.9K |
| Free Cash Flow | — | — | 275.9K |
| Rev Growth | +14.7% | +14.7% | -7.0% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |